DK1626992T3 - Produktion af rekombinant IgM i PER.C6-celler - Google Patents
Produktion af rekombinant IgM i PER.C6-cellerInfo
- Publication number
- DK1626992T3 DK1626992T3 DK04741596.3T DK04741596T DK1626992T3 DK 1626992 T3 DK1626992 T3 DK 1626992T3 DK 04741596 T DK04741596 T DK 04741596T DK 1626992 T3 DK1626992 T3 DK 1626992T3
- Authority
- DK
- Denmark
- Prior art keywords
- production
- igm
- cells
- per
- recombinant igm
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3046—Stomach, Intestines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP0350194 | 2003-05-23 | ||
PCT/EP2004/050844 WO2004104046A1 (en) | 2003-05-23 | 2004-05-18 | Production of recombinant igm in per.c6 cells |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1626992T3 true DK1626992T3 (da) | 2010-09-20 |
Family
ID=33462066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04741596.3T DK1626992T3 (da) | 2003-05-23 | 2004-05-18 | Produktion af rekombinant IgM i PER.C6-celler |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060063234A1 (da) |
EP (1) | EP1626992B1 (da) |
AT (1) | ATE469920T1 (da) |
AU (1) | AU2004240782B2 (da) |
CA (1) | CA2521490C (da) |
DE (1) | DE602004027483D1 (da) |
DK (1) | DK1626992T3 (da) |
WO (1) | WO2004104046A1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7658924B2 (en) * | 2001-10-11 | 2010-02-09 | Amgen Inc. | Angiopoietin-2 specific binding agents |
JO2913B1 (en) * | 2008-02-20 | 2015-09-15 | امجين إنك, | Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses |
JP2014105159A (ja) * | 2012-11-22 | 2014-06-09 | Nippon Koden Corp | ヒト由来上皮細胞接着分子に対するモノクローナル抗体、およびこれを用いた循環腫瘍細胞の検出方法 |
KR102306492B1 (ko) | 2013-09-05 | 2021-09-29 | 아이쥐엠 바이오사이언스 인코포레이티드 | 불변 쇄 변형된 이특이적, 5가 및 6가 ig-m 항체 |
EP3560954B1 (en) | 2014-04-03 | 2021-08-04 | IGM Biosciences, Inc. | Modified j-chain |
BR112017018941B8 (pt) | 2015-03-04 | 2023-01-10 | Igm Biosciences Inc | Molécula de ligação a cd20, seu uso, composição e método in vitro para direcionar a morte mediada por complemento de uma célula que expressa cd20 |
CN108463245A (zh) | 2015-09-30 | 2018-08-28 | Igm生物科学有限公司 | 具有修饰的j链的结合分子 |
EP3356401B1 (en) | 2015-09-30 | 2020-06-24 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4703008A (en) * | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
NZ210501A (en) * | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
US4835260A (en) * | 1987-03-20 | 1989-05-30 | Genetics Institute, Inc. | Erythropoietin composition |
GB8719963D0 (en) * | 1987-08-24 | 1987-09-30 | Cattaneo A | Recombinant dna products |
US5192539A (en) * | 1988-07-21 | 1993-03-09 | Akzo N.V. | Infectious bursal disease virus production in continuous cell lines |
US5047335A (en) * | 1988-12-21 | 1991-09-10 | The Regents Of The University Of Calif. | Process for controlling intracellular glycosylation of proteins |
GB8900483D0 (en) * | 1989-01-10 | 1989-03-08 | Celltech Ltd | Recombinant dna method |
DE3923963A1 (de) * | 1989-07-20 | 1991-01-31 | Behringwerke Ag | Muteine des menschlichen erythropoetins, ihre herstellung und ihre verwendung |
US5856298A (en) * | 1989-10-13 | 1999-01-05 | Amgen Inc. | Erythropoietin isoforms |
US5384249A (en) * | 1991-12-17 | 1995-01-24 | Kyowa Hakko Kogyo Co., Ltd. | α2→3 sialyltransferase |
US5631158A (en) * | 1993-10-25 | 1997-05-20 | Creative Biomolecules, Inc. | Methods and compositions for high protein production from non-native DNA |
US5830851A (en) * | 1993-11-19 | 1998-11-03 | Affymax Technologies N.V. | Methods of administering peptides that bind to the erythropoietin receptor |
US5773569A (en) * | 1993-11-19 | 1998-06-30 | Affymax Technologies N.V. | Compounds and peptides that bind to the erythropoietin receptor |
US5789247A (en) * | 1994-04-01 | 1998-08-04 | Ballay; Annick | Expression in non-tumoral human lymphoblastoid lines with an integrative vector |
US5767078A (en) * | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
SI0833934T2 (sl) * | 1995-06-15 | 2013-04-30 | Crucell Holland B.V. | Pakirni sistemi za humani rekombinantni adenovirus za uporabo v genski terapiji |
CA2235629A1 (en) * | 1995-11-13 | 1997-05-22 | Takara Shuzo Co., Ltd. | Method for gene transfer into target cells with retrovirus |
US5835382A (en) * | 1996-04-26 | 1998-11-10 | The Scripps Research Institute | Small molecule mimetics of erythropoietin |
WO1999066041A1 (en) * | 1998-06-16 | 1999-12-23 | Human Genome Sciences, Inc. | 94 human secreted proteins |
US6670188B1 (en) * | 1998-04-24 | 2003-12-30 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
US6855544B1 (en) * | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
ES2237420T5 (es) * | 1999-04-15 | 2010-03-03 | Crucell Holland B.V. | Produccion de proteina recombinante en una celula humana. |
US6492169B1 (en) * | 1999-05-18 | 2002-12-10 | Crucell Holland, B.V. | Complementing cell lines |
US6558948B1 (en) * | 1999-11-23 | 2003-05-06 | Stefan Kochanek | Permanent amniocytic cell line, its production and use for the production of gene transfer vectors |
ATE536375T1 (de) * | 2000-05-10 | 2011-12-15 | Mayo Foundation | Menschliche igm antikörper, welche die fähigkeit besitzen, den wiederaufbau der myelinstruktur zu induzieren und deren diagnostische und therapeutische anwendung im zentralen nervensystem |
US7151164B2 (en) * | 2002-02-14 | 2006-12-19 | Immunomedics, Inc. | Anti-CD20 antibodies and fusion proteins thereof and methods of use |
PT2314629E (pt) * | 2002-07-18 | 2014-01-22 | Merus B V | Produção recombinante de misturas de anticorpos |
-
2004
- 2004-05-18 DK DK04741596.3T patent/DK1626992T3/da active
- 2004-05-18 EP EP04741596A patent/EP1626992B1/en not_active Expired - Lifetime
- 2004-05-18 AU AU2004240782A patent/AU2004240782B2/en not_active Ceased
- 2004-05-18 CA CA2521490A patent/CA2521490C/en not_active Expired - Fee Related
- 2004-05-18 DE DE602004027483T patent/DE602004027483D1/de not_active Expired - Lifetime
- 2004-05-18 WO PCT/EP2004/050844 patent/WO2004104046A1/en active Application Filing
- 2004-05-18 AT AT04741596T patent/ATE469920T1/de active
-
2005
- 2005-11-09 US US11/271,090 patent/US20060063234A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1626992B1 (en) | 2010-06-02 |
AU2004240782B2 (en) | 2011-04-21 |
AU2004240782A1 (en) | 2004-12-02 |
CA2521490C (en) | 2013-07-30 |
US20060063234A1 (en) | 2006-03-23 |
WO2004104046A1 (en) | 2004-12-02 |
EP1626992A1 (en) | 2006-02-22 |
ATE469920T1 (de) | 2010-06-15 |
CA2521490A1 (en) | 2004-12-02 |
DE602004027483D1 (de) | 2010-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60324430D1 (de) | Methode um rekombinante proteine in cho zellen zu exprimieren | |
WO2003104418A3 (en) | RECONSTITUTED POLYPEPTIDES | |
ATE516343T1 (de) | Zellinien zur produktion von replikationsdefektem adenovirus | |
DK1210411T3 (da) | Sammensætninger og fremgangsmåder til forbedret celledyrkning | |
DK1007698T3 (da) | Ekspression af heterologe proteiner | |
DE60144145D1 (de) | Subtilisin-variante | |
ATE374828T1 (de) | Expressionsvektor zur antibiotikafreien expression | |
PL1685243T3 (pl) | Unieśmiertelnione ptasie linie komórkowe do wytwarzania wirusów | |
NO20052276D0 (no) | Sirkulaert DNA-molekyl med en kondisjonell replikasjonsorigo, fremgangsmate for deres fremstilling og deres anvendelse i genterapi | |
EP1751282A4 (en) | PRODUCTION OF HOST CELLS CONTAINING MULTIPLE INTEGRATED VECTORS THROUGH SERIAL TRANSDUCTION | |
ATE527349T1 (de) | Nervenregeneration | |
CY1118782T1 (el) | Επιλογη κυτταρων που εκφραζουν ετερομερη πολυπεπτιδια | |
WO2005003315A3 (en) | Compositions and methods for peptide-assisted transfection | |
WO2005028626A3 (en) | Cell culture media | |
ATE278024T1 (de) | Methode zur herstellung von rekombinanten zellen | |
HUP0303843A2 (hu) | CLyA-hemolizin alkalmazása proteinek exkretáltatására | |
DK1626992T3 (da) | Produktion af rekombinant IgM i PER.C6-celler | |
IL180531A0 (en) | Novel sequence for improving expression of nucleic acid | |
WO2003078576A3 (en) | Vector for transfection of eukaryotic cells | |
DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
ATE546531T1 (de) | Transaktivierungssystem für säugerzellen | |
DE69934903D1 (de) | Mitogene regulatoren | |
DK1131408T3 (da) | Celler, dyrkningsmetoder og deres anvendelse ved autolog transplantationsbehandling | |
ATE464320T1 (de) | Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) | |
WO2003021265A8 (en) | Genetic construct intracellular monitoring system |